AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas
AR42 是一种新型组蛋白去乙酰化酶抑制剂，可作为前庭神经鞘瘤和脑膜瘤的潜在治疗方法
期刊:Neuro-Oncology
影响因子:16.4
doi:10.1093/neuonc/nor072
Matthew L Bush, Janet Oblinger, Victoria Brendel, Griffin Santarelli, Jie Huang, Elena M Akhmametyeva, Sarah S Burns, Justin Wheeler, Jeremy Davis, Charles W Yates, Abhik R Chaudhury, Samuel Kulp, Ching-Shih Chen, Long-Sheng Chang, D Bradley Welling, Abraham Jacob
